{"DataElement":{"publicId":"3837204","version":"1","preferredName":"Pharmacokinetics Preparative Regimen Medication Dose Assessment Area Under Curve Milligram per Milliliter per Minute Value","preferredDefinition":"The area under curve milligram per milliliter per minute numeric value measured, assigned or computed related to the assessment of pharmacokinetics preparative regimen drug dosing.","longName":"2816465v1.0:3962795v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2816465","version":"1","preferredName":"Pharmacokinetics Preparative Regimen Medication Dose Assessment","preferredDefinition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements._The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur._A drug or medicine that treats or prevents or alleviates the symptoms of disease._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._The final result of a determination of the value, significance, or extent of.","longName":"2816462v1.0:2971612v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2751994","version":"1","preferredName":"Pharmacokinetics","preferredDefinition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","longName":"C15299","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetics","conceptCode":"C15299","definition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DDF198E-B7E3-2C9D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-22","endDate":null,"createdBy":"UMLLOADER_LEADS","dateCreated":"2008-05-23","modifiedBy":"ONEDATA","dateModified":"2008-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3028375","version":"1","preferredName":"Preparative Regimen Medication Dose Assessment","preferredDefinition":"The chemotherapy and/or radiation given to bone marrow transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur.:biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products.:The amount of medicine taken, or radiation given, at one time.:Having determined the value, significance, or extent of.","longName":"C61155:C459:C25488:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8223B6A1-97DB-C0E8-E040-BB89AD43538F","latestVersionIndicator":"Yes","beginDate":"2010-03-19","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-19","modifiedBy":"ONEDATA","dateModified":"2010-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E2CC7C4-1C8C-4D3B-E040-BB89A6436990","latestVersionIndicator":"Yes","beginDate":"2008-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-12-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".Updated def for prep reg, no version needed. AK 12/20/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3962795","version":"1","preferredName":"Area Under Curve Milligram per Milliliter per Minute Value","preferredDefinition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated._A dose calculation unit equal to mass concentration of a substance expressed in kilograms per unit volume of the mixture equal to one cubic meter per time period of one minute._A numerical quantity measured or assigned or computed.","longName":"3962795v1.0","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"mg/mL/minute","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3962794","version":"1","preferredName":"Area under Curve Milligram per Milliliter per Minute Value","preferredDefinition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.:A dose calculation unit equal to mass concentration of a substance expressed in kilograms per unit volume of the mixture equal to one cubic meter per time period of one minute.:A numerical quantity measured or assigned or computed.","longName":"C64774:C67403:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Area Under Curve","conceptCode":"C64774","definition":"The area between the x-axis and the curve given by the integrand. It is equal to the definite integral of a function. In the field of pharmacokinetics, the area under the curve (AUC) is the area under the curve in a plot of concentration of a drug in plasma against time. AUC is usually given for the time interval zero to infinity, and other time intervals are indicated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Milligram per Milliliter per Minute","conceptCode":"C67403","definition":"A dose calculation unit equal to mass concentration of a substance expressed in kilograms per unit volume of the mixture equal to one cubic meter per time period of one minute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC042D76-C677-91BE-E040-BB89AD43598C","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-25","modifiedBy":"ONEDATA","dateModified":"2013-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC042D76-C688-91BE-E040-BB89AD43598C","latestVersionIndicator":"Yes","beginDate":"2013-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-25","modifiedBy":"KUMMEROA","dateModified":"2014-01-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PreTed_pre_hct_carboplatin_target_auc_mg_ml_min","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the pharmacokinetics","type":"Preferred Question Text","description":"What is the pharmacokinetics preparative regimen drug dosing area under the curve value?","url":null,"context":"NHLBI"},{"name":"Specify the target AUC:","type":"Alternate Question Text","description":"Specify the target AUC:","url":null,"context":"NHLBI"},{"name":"Specify the target AUC:","type":"Application Standard Question Text","description":"Specify the target AUC:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2F8E14D-75D3-9D6C-E040-BB89AD431019","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-02","modifiedBy":"KUMMEROA","dateModified":"2014-11-18","changeDescription":".5/19/14mn-removed alt name that no longer exists: PreTed_pre_hct_pharmaco_target_auc_mg_ml_min. Added human readable def. System generated def displayed as alt def. No version needed. AK 11/18/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}